MDxHealth SA Gross Profit 2018-2024 | MDXH

MDxHealth SA gross profit from 2018 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
MDxHealth SA Annual Gross Profit
(Millions of US $)
2024 $55
2023 $44
2022 $19
2021 $11
2020 $8
2019 $0
2018 $17
2017 $30
2016 $30
MDxHealth SA Quarterly Gross Profit
(Millions of US $)
2024-09-30 $14
2024-06-30 $13
2024-03-31 $12
2023-12-31 $13
2023-09-30 $13
2023-06-30 $10
2023-03-31 $9
2022-12-31
2022-09-30 $6
2022-06-30
2022-03-31 $3
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.084B $0.090B
MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.096B 54.00
Hims & Hers Health (HIMS) United States $13.681B 142.14
Tempus AI (TEM) United States $11.156B 0.00
Inspire Medical Systems (INSP) United States $4.596B 71.81
IRhythm Technologies (IRTC) United States $4.484B 0.00
Privia Health (PRVA) United States $2.963B 202.50
Enovis (ENOV) United States $2.069B 11.53
Schrodinger (SDGR) United States $1.747B 0.00
Clover Health Investments (CLOV) United States $1.691B 0.00
Phreesia (PHR) United States $1.537B 0.00
Omnicell (OMCL) United States $1.346B 23.74
Azenta (AZTA) United States $1.233B 57.32
10x Genomics (TXG) United States $1.115B 0.00
Fulgent Genetics (FLGT) United States $0.599B 0.00
Butterfly Network (BFLY) United States $0.571B 0.00
Talkspace (TALK) United States $0.517B 154.50
Veradigm (MDRX) United States $0.455B 0.00
Claritev (CTEV) United States $0.435B 0.00
Standard BioTools (LAB) United States $0.406B 0.00
TruBridge (TBRG) United States $0.372B 825.00
Health Catalyst (HCAT) United States $0.291B 0.00
Nyxoah SA (NYXH) Belgium $0.206B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.205B 0.00
EUDA Health Holdings (EUDA) Singapore $0.146B 0.00
Pulmonx (LUNG) United States $0.131B 0.00
American Well (AMWL) United States $0.111B 0.00
CareCloud (CCLD) United States $0.086B 3.27
Retrieve Medical Holdings (RMHI) United States $0.083B 0.00
Outset Medical (OM) United States $0.067B 0.00
111 (YI) China $0.065B 0.00
P3 Health Partners (PIII) United States $0.059B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Zepp Health (ZEPP) Netherlands $0.041B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.011B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00